Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
CYCC on Nasdaq
Shares outstanding
1,584,707
Price per share
$0.32
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-200
Value change
-$56
Number of holders
0
Price from insider filings
$0.32
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Doris Wong Sing Ee 70% $52,549,781 194,628,820 Doris Wong Sing Ee 26 Feb 2025
ARMISTICE CAPITAL, LLC 9.2% -7.9% $6,708,076 +$6,480,818 24,844,725 +2852% Armistice Capital, LLC 31 Mar 2025

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC). This represents 0% of the company’s total 1,584,707 outstanding shares.

Institutional Holders of Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$56 $0.32 0
2025 Q2 0 $0 -$454,118 $0.32 0
2025 Q1 1,626,479 $454,098 +$256,532 $0.28 20
2024 Q4 704,042 $264,423 +$188,226 $0.38 17
2024 Q3 202,365 $200,198 -$40,810 $0.99 14
2024 Q2 229,309 $371,012 +$262,753 $1.62 16
2024 Q1 60,593 $126,739 -$90,802 $2.11 12
2023 Q4 93,921 $249,543 +$249,328 $2.67 13